Pulmonary surfactants, synthesized by alveolar type II cells, are a mixture of a large amount of phospholipid and a small amount of a specific protein which help to keep the lungs expanded by lowering the surface tension at the airwater interface in the alveoli.
synthesis were purchased from Kokusan Chemical Works, Ltd. (Tokyo, Japan) and Nihon Perseptive, Ltd. (Tokyo, Japan). DPPC, PG (sodium salt prepared from egg yolk phosphatidylcholine), and human albumin were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). PA was from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan). Surfactant TA was a modified bovine lung surfactant containing a small percentage of proteins and about 95% lipids, and was supplied by Mitsubishi Pharma Co., Ltd. (Tokyo, Japan). All other chemicals were of reagent grade.
Synthesis and Purification of SP-CL16 (6-28) Peptide synthesis was carried out using the stepwise solid-phase method with a peptide synthesizer (Pepsynthesizer model 9050 plus, Nihon PerSeptive) as described previously. 7) The purification of cleaved peptide was described in detail previously. 8) Briefly, the peptide was purified by centrifugal partition chromatography (CPC) performed on a model LLN-B (Sanki Engineering, Tokyo, Japan) machine equipped with a 2056-cartridge column and developed with the nhexane/CH 3 OH/H 2 O/trifluoroacetic acid (TFA) solvent system using the descending method. Purified peptide was stored at Ϫ20°C.
Analysis of Synthetic Peptide by Mass Spectrometry
The peptide was identified using an electrospray ionization mass spectrometric analyzer model Quatro LC (JASCO International, Tokyo, Japan).
Quantitative Amino Acid Analysis The composition of the purified peptide was determined as described previously.
8)
Preparation of SLS SLS containing the peptide was prepared in the following manner 7) : Synthetic peptide dissolved in a small volume of TFA was mixed with a ternary lipid mixture of DPPC/PG/PA (75 : 25 : 10, w/w) in a CHCl 3 / CH 3 OH (2 : 1, v/v) solution to produce a peptide-lipid mixture containing 2% peptide on a weight/weight basis relative to the phospholipids. The peptide-lipid mixture was suspended in 10% ethanol, incubated at 40-45°C for 15 min and then lyophilized to obtain a white powder. This admix-ture was dispersed in saline by sonication for 1 min in icecold water and stored in nitrogen at Ϫ20°C. The final concentration of phospholipids was 10 mg/ml. Surfactant-TA was also dispersed in saline at a phospholipid concentration of 25 mg/ml.
Measurement of Surface Activity with WSB Synthetic surfactant containing peptide was prepared in the following manner. 7) Synthetic peptide dissolved in a small volume of TFA was mixed with the ternary lipid mixture of DPPC/ PG/PA (75 : 25 : 10, w/w) in a CHCl 3 /CH 3 OH (2 : 1, v/v) solution to produce a peptide-lipid mixture containing 2% peptide on a weight/weight basis relative to the phospholipids. The peptide-lipid mixture was suspended in a 10% ethanol solution, incubated at 40-45°C for 15 min, and then lyophilized to obtain a white powder. This admixture was dispersed in saline by sonication for 1 min in ice-cold water and was stored in nitrogen at Ϫ20°C. The final concentration of phospholipids was 10 mg/ml. The assays were performed using human albumin at a concentration of 0.1-10 mg/ml.
Surfactant-TA was also dispersed in saline at a phospholipid concentration of 25 mg/ml.
Measurement of Surface Activities Using PBS Surface tension was measured during dynamic compression using a PBS as described. 9) Briefly, a bubble of ambient air drawn through a small tube is formed in a chamber containing a surfactant suspension. This bubble is pulsated at 37Ϯ1°C at a rate of 20 cycles/min between a fixed radius (0.4-0.55 mm), resulting in a 50% change in surface area. The pressure across the bubble is measured with a pressure transducer, and the surface tension can be calculated from the law of Laplace: Pϭ2g/r. All surfactant samples assayed on the PBS were made up in buffers containing saline. These SLSs were assayed at a concentration of 1 mg/ml, or combined with albumin 1-10 mg/ml.
Measurement of Surface Activities Using MBT The MBT described by Pattle and Kratzing 10) is based on the ability of a pulmonary surfactant to generate stable microbubbles that are less than 15 mm in diameter. Briefly, the surfactant sample was swirled to resuspend the sediment. An aliquot was aspirated 5 cm up the stem (ca. 40 ml) with a Pasteur pipette that had a lumen 1 mm in diameter and a stem 11.5 cm long (Pyrex, Corning Lab. Sci. Co., Corning, NY, U.S.A.) using a 2 ml rubber cap, and was placed on a 35 mmϫ50 mm i.d. microslide. The drop was then sucked into and expelled from the pipette 20 times in quick succession with the tip touching the slide vertically. This process took about 6 s, and if correctly performed makes a characteristic sound. The slide was then immediately inverted over a hollow slide, so that a hanging drop was formed. After 4 min, the slide was examined under the 10ϫobjective lens of a microscope using a 1 mm 2 field and a 15 mm scale. Counts were made in five regions in four quadrants and at the center of the bubble field. All stable microbubbles less than 15 mm in diameter were counted. The mean count of micro bubbles/mm 2 of five regions was calculated.
Data Analyses Statistical analyses were performed using Student's unpaired t-test. All data are expressed as the meanϮS.D. p values of less than 0.01 were considered to indicate a statistically significant difference.
RESULTS

Effect of Surface Activity of Synthetic Surfactant in WSB
The surface activity of the SLS improved the in vitro surface activity of a ternary lipid mixture composed of DPPC/PG/PA (75 : 25 : 10, w/w) in WSB. The levels of surface activity are shown in Table 1 . Table 1 summarizes the effect of the spreading kinetics and dynamic compressionexpression properties of the lipid mixture of DPPC/PG/PA and SLS with albumin.
DPPC/PG/PA significantly lost surface activity in the presence of albumin. The surface tension reached 55.8 mN/m at 120 s. After 3 min of spreading, the surface tension area diagrams of the surfactant film during dynamic cycling were measured with phospholipids at an internal concentration of 1.5 mg/cm 2 . Film containing albumin at a concentration of 0.1-10 mg/ml did not exhibit surface tension of less than 10 mN/m and exhibited the minimum surface tension (g min ) and maximum surface tension (g max ) of 23.7 mN/m and 54.5 mN/m, respectively. With the SLS containing 10 mg/ml of albumin, after 3 min of spreading the surface tension was more than 10 mN/m, and the minimum and maximum sur- a) A ternary lipid mixture of DPPC/PG/PA (75 : 25 : 10, w/w) admixed with SP-CL16 (6-28) at 2% of the weight of phospholipids was applied to the air-water interface with 1.5 mg of phospholipids/cm 2 surface area and allowed to spread spontaneously for 120 s. The albumin concentration was 0.1-10 mg/ml. The surface area was then chosen from an area of 54.0 to 21.6 cmface tension was 18.3 mN/m and 40.5 mN/m, respectively. Fig.  1 . Figures 2 and 3 illustrate the kinetics of surface tension of a synthetic surfactant containing a ternary lipid mixture (DPPC/PG/PA) and composed of SP-CL16 (6-28) and surfactant-TA.
Kinetics of the Surface Activity of the Synthetic Surfactant in a PBS Surface adsorption values shown in
The surface tension of SLS after the surfactant sample was allowed to stand for 10 s (surface adsorption) was 25.6 mN/m. That of surfactant-TA was 24.6 mN/m. In contrast, DPPC/PG/PA had a surface tension of 52.7 mN/m. Moreover, SLS remarkably increased the surface activity as compared with DPPC/PG/PA. The g min value was 7-9 mN/m at a kinetics time of 0.25-5 min. The g max value was about 33 mN/m at all time points. SLS and surfactant-TA showed the good surface activity comparable to that of DPPC/PG/PA after 5 min.
Effect of Albumin on the Surface Activity of Synthetic Surfactant in a PBS The surface activity values are listed in Figs. 4A-C. Synthetic surfactant was found to have no effect on surface adsorption and g max using a PBS. DPPC/ PG/PA significantly inhibited the g min in a dosage-dependent manner.
The surface activities were 29.8 mN/m, 35.7 mN/m, and 42.3 mN/m at albumin concentrations of 0.1-10 mg/ml. In contrast, SLS and surfactant-TA did not inhibit the surface activity.
Effect of Albumin on Surface Activity of Synthetic Surfactant in a MBT Stable bubbles of albumin were not observed in the MBT. Bubbles of DPPC/PG/PA, SLS, and surfactant-TA with untreated albumin totaled 110Ϯ12, 128Ϯ12.5 and 123Ϯ12.3, respectively, at a concentration of surfactant sample of 10 mg/ml after stabilizing for 4 min.
The findings are shown in Fig. 5 . In this experiment, DPPC/PG/PA, SLS, and surfactant-TA inhibited the number of stable bubbles formed from albumin in a dose-dependent manner (0.1-10 mg/ml) (Fig. 5A) . In contrast, at a concentration of 0.1 mg/ml of surfactant sample (Fig. 5B) , the number of bubbles that DPPC/PG/PA, SLS, and surfactant-TA produced from untreated albumin was 18Ϯ2.3, 18Ϯ3.2 and 21Ϯ1.5, respectively, after 4 min.
All surfactant samples showed a marked decrease in the number of stable microbubbles produced by albumin at a concentration of 10 mg/ml. DPPC/PG/PA and SLS inhibited the formation of microbubbles at 0.1-10 mg/ml dose dependently. Surfactant-TA decreased the number at 0.1 mg/ml.
DISCUSSION
The purpose of the present study was to characterize the surface activity of synthetic surfactants, which is inhibited by serum inhibitors. We previously synthesized human SP-C analogues and found the polyleucine substituted analogues to be comparable in surface activity with surfactant-TA, a modified surfactant 7) which has been used for the treatment of RDS. 8) We also examined the biological activity as an antiproinflammatory using human monocyte cells. 11) We believe that the experiment a strategy of measuring the influence of surface activity using inhibitors is the optimal examination in simple compounds so that the characterization is easily understood. Therefore we selected albumin as a typical inhibitor in this study. For the evaluation, we measured the influence of albumin on the surface activity of surfactants using the WSB, PBS, and MBT. In the WSB, the surface activity was decreased remarkably by albumin at a low concentration at which DPPC/PG/PA does not contain SP-CL16 (6-28) protein. SLS confirmed the decease of sur- PBS is similar to the human physiological respiratory mechanism since the compression period at the front face of the liquid phase of physiological saline is as short as 20 cycles/min and the surface pressure is decreased by 50%. The g min excess of 10 mN/m is reported to be the value at which an alveolus cannot maintain respiratory function. 12, 13) As shown in Figs. 2 and 3 , stability evaluation of respiratory function indicated that surface activity should be measuring a surface after 5 min. Therefore we established the following criteria for PBS: g min is less than 10 mN/m at after 5 min pulsation, and surface adsorption is less than 35 mN/m after the sample is allowed to stand for 10 s. The concentration of sample is measured with at a dosage of 1.0-2.5 mg/ml in PBS. 14, 15) Based on this knowledge, we used a measurement concentration of 2.5 mg/ml. The surface adsorption and g max of three types of surfactant were not influenced by albumin concentrations of 0.1-10 mg/ml. However, DPPC/PG/PA showed a remarkable decrease in g min that was dependent on the albumin concentration. The g min value of surfactant-TA was controlled by albumin 10 mg/ml. SLS satisfied the criteria in the presence of albumin.
The MBT is widely used in the diagnosis of RDS. 16 ) Based on a report on the measurement method, 17) we chose surfactant concentrations of 1 and 10 mg/ml. If albumin intermingles with the surfactant, it is reported that repulsion phenomenon observed differs in vitro and in vivo.
18) Kabata and Xiao 19) reported on the effects of a natural surfactant and inhibitor on surface activity. According to their report, the mixture of surfactant and albumin decreased the surface activity in vitro. However, the activity was not influenced by albumin and the respiratory function improved in vivo. This finding reflects the repulsion phenomenon. In the MBT, the number of stable bubbles increased in the mixed sample of natural surfactant-TA and albumin at a concentration of 0.1 mg/ml (Fig. 5B) . This result is assumed to reflect the repulsion phenomenon.
In this study, synthetic surfactant containing surfactant protein was only slightly influenced compared with the DPPC/PG/PA surfactant without protein by albumin which is an active inhibitor of surface activity. That is, stable microbubbles were confirmed to increase with the concentration of surfactant-TA (1 mg/ml) and albumin (0.1 mg/ml) in the MBT. No such phenomenon with SLS. Therefore the repulsion phenomenon is specific to natural surfactant. SLS influenced less by albumin (0.1-10 mg/ml) as compared with a ternary mixture of phospholipids in vitro. The influence of the inhibitor on the surface activity of SLS has been characterized using the WSB, PBS, and MBT. We speculate that the surface activity of SLS is not affected by interaction with albumin. The possibility exists that a synthetic surfactant that is not influenced by an active inhibitor can be systematically optimized using the repulsion phenomenon.
